Recombinant Human CCL22 protein, GST-tagged
|Product Overview :||Recombinant Human CCL22 protein(O00626)(25-82aa), fused to N-terminal GST tag, was expressed in E. coli.|
- Gene Information
- Related Products
|Source :||E. coli|
|Form :||If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol.
If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
|Molecular Mass :||33.7 kDa|
|Protein length :||25-82aa|
|Purity :||Greater than 90% as determined by SDS-PAGE.|
|Storage :||Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.|
|Reconstitution :||Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%.|
|Gene Name :||CCL22 chemokine (C-C motif) ligand 22 [ Homo sapiens ]|
|Official Symbol :||CCL22|
|Synonyms :||CCL22; chemokine (C-C motif) ligand 22; SCYA22, small inducible cytokine subfamily A (Cys Cys), member 22; C-C motif chemokine 22; A 152E5.1; ABCD 1; DC/B CK; MDC; MGC34554; STCP 1; MDC(1-69); CC chemokine STCP-1; macrophage-derived chemokine; small inducible cytokine A22; small-inducible cytokine A22; stimulated T cell chemotactic protein 1; stimulated T-cell chemotactic protein 1; small inducible cytokine subfamily A (Cys-Cys), member 22; ABCD-1; SCYA22; STCP-1; DC/B-CK; A-152E5.1;|
|Gene ID :||6367|
|mRNA Refseq :||NM_002990|
|Protein Refseq :||NP_002981|
|UniProt ID :||O00626|
|◆ Recombinant Protein|
|CCL22-081C||Active Recombinant Human CCL22 Protein (69 aa)||+Inquiry|
|CCL22-1108P||Recombinant Pig CCL22 Protein, His-tagged||+Inquiry|
|CCL22-311H||Recombinant Human CCL22 Protein, His-tagged||+Inquiry|
|CCL22-2884M||Recombinant Mouse CCL22 Protein||+Inquiry|
|Ccl22-131M||Active Recombinant Mouse Ccl22 Protein||+Inquiry|
|CCL22-7728HCL||Recombinant Human CCL22 293 Cell Lysate||+Inquiry|
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Q&As (6)Ask a question
The expression of CCL22 gene is regulated by a variety of signaling pathways, including inflammatory factor-mediated signaling pathways, cytokine-mediated signaling pathways, and transcription factors.
Studies have shown that by interfering with the interaction of the CCL22 protein and its receptor CCR4, tumor growth, improve inflammatory response, and regulate autoimmune diseases can be inhibited. These findings provide potential application value for the development of corresponding therapeutic strategies.
A number of inhibitors or antagonists that interact with CCL22 proteins have been developed that block the binding of CCL22 to its receptor CCR4, thereby interfering with its biological function.
The mechanism of action of CCL22 protein in specific diseases can be studied through cell culture experiments, animal models, clinical samples, and related biochemical techniques.
There are complex interactions between CCL22 proteins and other chemokines. They may influence the migration and localization of immune cells by competing for receptors, mutual regulation of expression, etc.
Some studies have shown that in tumor immunotherapy, inhibiting the expression of CCL22 or interfering with its interaction with CCR4 can enhance the effect of immunotherapy and improve the survival rate of patients.
Customer Reviews (0)Write a review
Ask a Question for All CCL22 Products
Required fields are marked with *
My Review for All CCL22 Products
Required fields are marked with *